| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ff81a650b70e913d3b2524b45e4c7320 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 |
| filingDate |
1999-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10df5e3eb893b8c0afbb6d99d7dd0a04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68d109e5c050e648161877bf38e69525
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6e73db193fb257b6958ee4ae8c349e2 |
| publicationDate |
2000-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2343038-A1 |
| titleOfInvention |
A novel inhibitor of cataract formation |
| abstract |
Methods of reducing the risk of cataract development in a mammal are provide d and include administering to the mammal an effective amount of a tetracyclin e derivative. A preferred tetracycline derivative administered according to th e methods of the present invention is 6.alpha.-deoxy 5-hydroxy-4- dedimethylaminotetracycline. |
| priorityDate |
1998-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |